Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
CALL
Cameco
CCJ
$37.6B
| $824K | ﹤0.01% |
37,800
-662,000
| -95% | -$16M |
|
2927
Euronet Worldwide
EEFT
$2.72B
| $824K | ﹤0.01% |
6,911
-334
| -5% | -$39.7K |
|
2928
CALL
International Paper
IP
$21.6B
| $822K | ﹤0.01% |
17,500
-180,500
| -91% | -$8.9M |
|
2929
Silgan Holdings
SLGN
$4.23B
| $822K | ﹤0.01% |
19,208
-26,308
| -58% | -$1.09M |
|
|
QTNT
2930
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $822K | ﹤0.01% |
7,937
+1,292
| +19% | +$124K |
|
2931
eHealth
EHTH
$42.2M
| $821K | ﹤0.01% |
32,192
+13,015
| +68% | +$432K |
|
2932
Workhorse Group
WKHS
$33.2M
| $821K | ﹤0.01% |
63
-17
| -21% | -$309K |
|
|
BLUE
2933
DELISTED
bluebird bio
BLUE
| $819K | ﹤0.01% |
4,099
-3,137
| -43% | -$740K |
|
2934
Gossamer Bio
GOSS
$82.9M
| $819K | ﹤0.01% |
+72,450
| New | +$861K |
|
2935
International Seaways
INSW
$4.76B
| $819K | ﹤0.01% |
55,816
+37,024
| +197% | +$613K |
|
2936
JD.com
JD
$44.6B
| $817K | ﹤0.01% |
11,659
+7,393
| +173% | +$585K |
|
2937
Mercury Insurance
MCY
$5.93B
| $817K | ﹤0.01% |
15,398
-53,087
| -78% | -$2.85M |
|
2938
Herbalife
HLF
$1.29B
| $816K | ﹤0.01% |
19,949
-20,284
| -50% | -$844K |
|
2939
AnaptysBio
ANAB
$1.58B
| $813K | ﹤0.01% |
23,403
+11,674
| +100% | +$370K |
|
2940
OraSure Technologies
OSUR
$279M
| $813K | ﹤0.01% |
93,474
+26,348
| +39% | +$260K |
|
2941
Costamare
CMRE
$1.88B
| $811K | ﹤0.01% |
64,075
+17,571
| +38% | +$230K |
|
2942
ProShares UltraPro Russell2000
URTY
$322M
| $810K | ﹤0.01% |
8,010
+7,793
| +3,591% | +$841K |
|
|
HUYA
2943
CALL
Huya Inc
HUYA
$563M
| $809K | ﹤0.01% |
116,500
| – | – |
|
|
SP
2944
DELISTED
SP Plus Corporation
SP
| $809K | ﹤0.01% |
28,681
+18,629
| +185% | +$558K |
|
|
MRC
2945
DELISTED
MRC Global
MRC
| $807K | ﹤0.01% |
117,415
+73,027
| +165% | +$572K |
|
2946
PUT
UnitedHealth
UNH
$376B
| $803K | ﹤0.01% |
1,600
| – | – |
|
2947
Hovnanian Enterprises
HOV
$726M
| $800K | ﹤0.01% |
6,289
+4,196
| +200% | +$414K |
|
|
CVET
2948
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
| $799K | ﹤0.01% |
+40,000
| New | +$753K |
|
2949
CALL
ProShares UltraPro QQQ
TQQQ
$32.1B
| $798K | ﹤0.01% |
19,200
| – | – |
|
|
CPRX
2950
DELISTED
Catalyst Pharmaceutical
CPRX
| $797K | ﹤0.01% |
117,860
+55,238
| +88% | +$363K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.